跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PLGA Nanoparticles
首页
药物
PLGA Nanoparticles
PLGA Nanoparticles
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
FORMULATION OF ACTIVE AGENT LOADED ACTIVATED PLGA NANOPARTICLES FOR TARGETED CANCER NANO-THERAPEUTICS
EP 2146694 A4
申请人: UNIV NORTH TEXAS
优先权: 2007
EP
US
WO
6 件公开
PLGA-modified polyethylenimine self-assembly nanotechnology for nucleic acid and drug delivery
US 10246560 B2
申请人: BAYLOR COLLEGE MEDICINE
优先权: 2013
CN
US
3 件公开
THERAPEUTIC NANOPARTICLES WHICH ENCAPSULATE TERPENOIDS AND/OR CANNABINOIDS
EP 3878440 A1
申请人: GBS GLOBAL BIOPHARMA INC
优先权: 2018
EP
US
3 件公开
NANOPARTICLES BASED ON POLY (LACTIC GLYCOLIC) ACID FOR COSMETIC APPLICATIONS
US 2013266625 A1
申请人: BENITA SIMON
优先权: 2011
CN
US
2 件公开
USE OF NANOPARTICLES FOR IMMUNOTHERAPY
EP 3576786 A1
申请人: LAMPRECHT ALF
优先权: 2017
EP
US
2 件公开
PLGA-PEG/PEI NANOPARTICLES AND METHODS OF USE
US 2021388393 A1
申请人: ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO
优先权: 2018
US
WO
2 件公开
MUCOADHESIVE-PLGA NANOPARTICLES
US 2024374705 A1
申请人: PRESTIGE BIOPHARMA IDC CO LTD
优先权: 2022
US
WO
2 件公开
NEW CLOFOCTOL FORMULATION
EP 4701628 A1
申请人: INST NAT SANTE RECH MED
优先权: 2023
EP
WO
2 件公开
COMPOSITION AND METHOD FOR SULFATED NON-ANTICOAGULANT LOW MOLECULAR WEIGHT HEPARINS IN CANCER AND TUMOR METASTASIS
US 2015132399 A1
申请人: MOUSA SHAKER A
优先权: 2014
US
2 件公开
Intravenous nanoparticles for targeting drug delivery and sustained drug release
US 2006233883 A1
申请人: ISHIHARA TSUTOMU
优先权: 2003
US
第 1 / 10 页
上一页
下一页
药物
反馈